56.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché INSP Giù?
Forum
Previsione
Precedente Chiudi:
$56.14
Aprire:
$56.05
Volume 24 ore:
1.09M
Relative Volume:
0.97
Capitalizzazione di mercato:
$1.63B
Reddito:
$911.98M
Utile/perdita netta:
$145.42M
Rapporto P/E:
11.42
EPS:
4.9642
Flusso di cassa netto:
$78.48M
1 W Prestazione:
+0.69%
1M Prestazione:
+5.70%
6M Prestazione:
-21.34%
1 anno Prestazione:
-64.09%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Nome
Inspire Medical Systems Inc
Settore
Industria
Telefono
763-957-5037
Indirizzo
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
56.70 | 1.63B | 911.98M | 145.42M | 78.48M | 4.9642 |
|
ABT
Abbott Laboratories
|
89.46 | 155.82B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
294.73 | 112.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
80.00 | 102.71B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
56.50 | 83.97B | 20.62B | 3.56B | 3.66B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
83.98 | 48.42B | 6.30B | 1.07B | 1.34B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-13 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Downgrade | Truist | Buy → Hold |
| 2025-12-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Aggiornamento | Truist | Hold → Buy |
| 2025-11-25 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Aggiornamento | Stifel | Hold → Buy |
| 2025-11-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-22 | Downgrade | UBS | Buy → Neutral |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Downgrade | Truist | Buy → Hold |
| 2024-11-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-05-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-04-19 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Iniziato | Jefferies | Buy |
| 2024-01-02 | Downgrade | Stifel | Buy → Hold |
| 2023-12-13 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-12-13 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-11-03 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-11-03 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Iniziato | JP Morgan | Overweight |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-15 | Iniziato | Goldman | Buy |
| 2020-06-18 | Reiterato | Piper Sandler | Overweight |
| 2020-05-18 | Iniziato | Lake Street | Buy |
| 2020-04-28 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Iniziato | Piper Sandler | Overweight |
| 2020-01-28 | Iniziato | Oppenheimer | Underperform |
| 2020-01-27 | Iniziato | Oppenheimer | Underperform |
| 2019-11-06 | Aggiornamento | Berenberg | Sell → Hold |
| 2019-02-05 | Iniziato | Dougherty & Company | Buy |
| 2018-11-28 | Iniziato | Berenberg | Sell |
| 2018-10-29 | Iniziato | Leerink Partners | Outperform |
| 2018-05-29 | Iniziato | Guggenheim | Buy |
| 2018-05-29 | Iniziato | Stifel | Buy |
| 2018-05-29 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Inspire Medical Systems Inc Borsa (INSP) Ultime notizie
Is It Time To Revisit Inspire Medical Systems (INSP) After A Sharp Share Price Pullback - Sahm
Vanguard reports 5.10% stake in Inspire Medical | INSP SEC FilingForm SCHEDULE 13G - Stock Titan
Why is Inspire (INSP) down 2.4% since last earnings report? - MSN
Is Inspire Medical Systems (INSP) Pricing In A Turnaround After A 66% One Year Slide? - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $3.54 Million Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical surges after KeyBanc sees CMS adding codes for Inspire V implant - MSN
Vanguard Portfolio Management (INSP) reports 5.71% ownership of Inspire Medical Systems - Stock Titan
Sleep apnea device maker Inspire Medical speaks at BofA on May 13 - Stock Titan
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Hasbro, Inc. (HAS), Humana Inc. (HUM), Ibotta, Inc. (IBTA), and Inspire Medical Systems, Inc. (INSP) - The Daily Tribune News
Analysts estimate Inspire Medical Systems (INSP) to report a decline in earnings: What to look out for - MSN
Here's why you should add Inspire Medical stock to your portfolio now - MSN
Analysts Estimate Inspire Medical Systems (INSP) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Inspire Medical Systems (INSP) Projected to Post Earnings on Monday - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 28% Potential Upside Amidst Healthcare Innovation - DirectorsTalk Interviews
Despite Q4 beats, Inspire Medical declines on revised 2026 revenue outlook - MSN
Inspire Medical Systems Stock Targets Lowered Ahead of Earnings - HarianBasis.co
Inspire jumps on major change to Medicare reimbursement - MSN
Inspire Medical Systems, Inc. (INSP) PT Reduced to $64 as Truist Updates MedTech Outlook Ahead of Q1 - Yahoo Finance
A Look At Inspire Medical Systems (INSP) Valuation After Recent Share Price Reset - simplywall.st
INSP (Inspire Medical Systems Inc.) Q4 2025 EPS beats estimates by wide margin even as shares dip slightly today.Annual Report - Xã Thanh Hà
Inspire Medical Systems Inc (INSP) Stock Up 4.2% and Still Under - GuruFocus
M&T Bank Corp Takes $85.87 Million Position in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems Hits Day Low at $51.88 Amid Price Pressure - Markets Mojo
How Inspire Medical Systems Inc. (INSP) Affects Rotational Strategy Timing - Stock Traders Daily
Inspire Medical Systems (NYSE:INSP) Shares Down 8.3%Time to Sell? - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Analysis: 25% Potential Upside Beckons Investors - DirectorsTalk Interviews
Hedge funds view Inspire Medical (INSP) as one of the best small-cap healthcare stocks - MSN
Is It Time To Revisit Inspire Medical Systems (INSP) After A Sharp Share Price Pullback? - Sahm
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Director at Inspire Medical Systems (INSP) receives 307-share stock grant - Stock Titan
Inspire Medical (INSP) director gets 342-share stock fee grant - Stock Titan
Director Ellis receives 518 Inspire Medical (INSP) shares as fees - Stock Titan
Director Tansey receives 308 Inspire Medical (INSP) shares as fees - Stock Titan
Inspire Sleep Apnea Lawsuit Alleges Man Suffered Hours of Electrical Shocks From Device - AboutLawsuits.com
Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Zacks Research - MarketBeat
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $64.00 by Analysts at Truist Financial - MarketBeat
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $64 - 富途牛牛
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2025 Earnings Call Transcript - MSN
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 3 - GuruFocus
Inspire Medical Systems Inc Azioni (INSP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):